Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H21Cl2NO3 |
| Molecular Weight | 382.281 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=O)COC1=CC(Cl)=C(CC2=CC(C(C)C)=C(O)C=C2)C(Cl)=C1
InChI
InChIKey=CQELSEDWYWTMDG-UHFFFAOYSA-N
InChI=1S/C19H21Cl2NO3/c1-11(2)14-6-12(4-5-18(14)23)7-15-16(20)8-13(9-17(15)21)25-10-19(24)22-3/h4-6,8-9,11,23H,7,10H2,1-3H3,(H,22,24)
| Molecular Formula | C19H21Cl2NO3 |
| Molecular Weight | 382.281 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:08:30 GMT 2023
by
admin
on
Sat Dec 16 19:08:30 GMT 2023
|
| Record UNII |
QTW4WC4BRX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
827821
Created by
admin on Sat Dec 16 19:08:30 GMT 2023 , Edited by admin on Sat Dec 16 19:08:30 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
QTW4WC4BRX
Created by
admin on Sat Dec 16 19:08:30 GMT 2023 , Edited by admin on Sat Dec 16 19:08:30 GMT 2023
|
PRIMARY | |||
|
132160637
Created by
admin on Sat Dec 16 19:08:30 GMT 2023 , Edited by admin on Sat Dec 16 19:08:30 GMT 2023
|
PRIMARY | |||
|
2156649-32-8
Created by
admin on Sat Dec 16 19:08:30 GMT 2023 , Edited by admin on Sat Dec 16 19:08:30 GMT 2023
|
PRIMARY | |||
|
300000037779
Created by
admin on Sat Dec 16 19:08:30 GMT 2023 , Edited by admin on Sat Dec 16 19:08:30 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLIC ENZYME -> SUBSTRATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
ABX-002 enhanced delivery of LL-340001 to the brain by 30x and induced T3-dependent gene expression in the brain and liver at 13 μg/kg p.o.
|
